Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the stu
| Condition(s) | Invasive Breast Cancer Early Stages |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years |
| Who can participate | Inclusion Criteria: * Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected. * Patients whose death or contact loss has not been previously collected in the databases of the original studies. Exclusion Criteria: * Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal. |
| Ages | 18 Years |
| Sex | Female |
| Lead sponsor | Spanish Breast Cancer Research Group |
| Locations | Pamplona, Navarre, Spain; Avilés, Principality of Asturias, Spain; San Cristóbal de La Laguna, Tenerife, Spain; A Coruña, Spain; A Coruña, Spain; Albacete, Spain (+67 more sites) |
| Start date | 2018-01-18 |
| NCT ID | NCT03390894 |
| Official listing | https://clinicaltrials.gov/study/NCT03390894 |